Get started
Author

Jake Anthony Deviley

Observed names: JA Deviley, Jake A Deviley, Jake A. Deviley, Jake Deviley
ORCID: 0000-0002-7135-1444
Observed ORCID: 0000-0002-7135-1444
OpenAlex ID: A5052079491
Increased Incidence of Giant Cell Arteritis After Introduction of a Live Varicella Zoster Virus Vaccine
2020 · William A Agger, Jake A Deviley, et al. · Open Forum Infectious Diseases · 11
Sequential treatment failures in response to BRAF/MEK and immune checkpoint inhibitors mediated by MAP2K2 and B2M mutations in melanoma
2019 · Craig S. Richmond, Yazhini Vallatharasu, et al. · Experimental and Molecular Pathology · 11
Recurrent strokes, central nervous system vasculitis, and acquired protein S deficiency secondary to varicella zoster in a child with AIDS
2018 · Jake A. Deviley, Darby Oldenburg, et al. · Journal of NeuroVirology · 4
Abstract 1317: Exceptional responses to crizotinib in breast cancer patients with somatic MET and ROS1 alterations
2019 · Benjamin M. Parsons, David R. Meier, et al. · Cancer Research · 2
The role of income and rurality in US cancer mortality: A SEER analysis.
2025 · Wade T Swenson, Emily McGovern, et al. · Journal of Clinical Oncology · 1
Abstract 1317: Exceptional responses to crizotinib in breast cancer patients with somatic MET and ROS1 alterations
2019 · Benjamin M. Parsons, David R. Meier, et al. · Experimental and Molecular Therapeutics · 1
Incidence of uveal melanoma surveillance and related outcomes in the immunotherapy era in a rural healthcare system.
2026 · Jake Anthony Deviley, Garrett Weber, et al. · Journal of Clinical Oncology
Immune related adverse events: Timing, identification patterns, and impact on survival.
2024 · Jake Anthony Deviley, Yacki Hayashi-Tanner, et al. · Journal of Clinical Oncology
Evaluation of immune related adverse events following extended interval dosing of immune checkpoint inhibitors.
2023 · Jake Anthony Deviley, Yacki Hayashi-Tanner, et al. · Journal of Clinical Oncology
Abstract P5-10-04: Exome sequencing in high breast and ovarian cancer incidence families which lack detectable mutations in established cancer susceptibility genes
2019 · PA Kenny, MA Girtman, et al. · Cancer Research
Works count: 10
Citation count: 30
H-index: 3
I10-index: 2
Year
Topic
Type